Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Creatd, Inc.CRTD · Entity 8175 | Director | June 10, 2022 | June 14, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Creatd, Inc.
Report date June 10, 2022 · Filed June 14, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,642 |
Reported balance
After 2022-06-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-10 · Grant · Acquired 13,642 · Balance 13,642 F1: On June 10, 2022, the Board of Directors (the "Board") of Creatd, Inc. (the "Company") approved that the independent members of the Board each receive compensation for serving on the Board, in the form of equity issued pursuant to the Creatd, Inc. 2022 Omnibus Securities and Incentive Plan, which remains subject to shareholder approval. The Restricted Stock Units (the "RSUs") issued are priced at fair market value at issuance, vest one year from the date of issuance and are issued quarterly. Ms. Bloor received 10,000 RSUs at the initial election, 2,922 RSUs for annual compensation, 480 RSUs as chair of the Compensation Committee, 120 RSUs as member of the Nominating and Corporate Governance Committee and 120 RSUs as member of the Audit Committee - 13,642 RSUs in total. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 10, 2022, the Board of Directors (the "Board") of Creatd, Inc. (the "Company") approved that the independent members of the Board each receive compensation for serving on the Board, in the form of equity issued pursuant to the Creatd, Inc. 2022 Omnibus Securities and Incentive Plan, which remains subject to shareholder approval. The Restricted Stock Units (the "RSUs") issued are priced at fair market value at issuance, vest one year from the date of issuance and are issued quarterly. Ms. Bloor received 10,000 RSUs at the initial election, 2,922 RSUs for annual compensation, 480 RSUs as chair of the Compensation Committee, 120 RSUs as member of the Nominating and Corporate Governance Committee and 120 RSUs as member of the Audit Committee - 13,642 RSUs in total.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2022 Filed Jun 14, 2022 23:31 UTC | Creatd, Inc. CRTD · Entity 8175 | GrantRestricted Stock Units · Derivative | 13,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-032880 · ownership.xml · derivative · entry 1 Bloor Joanna · CIK 0001914486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,642 Underlying: Common Stock · 13,642 shares Expires not disclosed F1 · derivative.exercise_price: On June 10, 2022, the Board of Directors (the "Board") of Creatd, Inc. (the "Company") approved that the independent members of the Board each receive compensation for serving on the Board, in the form of equity issued pursuant to the Creatd, Inc. 2022 Omnibus Securities and Incentive Plan, which remains subject to shareholder approval. The Restricted Stock Units (the "RSUs") issued are priced at fair market value at issuance, vest one year from the date of issuance and are issued quarterly. Ms. Bloor received 10,000 RSUs at the initial election, 2,922 RSUs for annual compensation, 480 RSUs as chair of the Compensation Committee, 120 RSUs as member of the Nominating and Corporate Governance Committee and 120 RSUs as member of the Audit Committee - 13,642 RSUs in total. F1 · derivative.exercise_date: On June 10, 2022, the Board of Directors (the "Board") of Creatd, Inc. (the "Company") approved that the independent members of the Board each receive compensation for serving on the Board, in the form of equity issued pursuant to the Creatd, Inc. 2022 Omnibus Securities and Incentive Plan, which remains subject to shareholder approval. The Restricted Stock Units (the "RSUs") issued are priced at fair market value at issuance, vest one year from the date of issuance and are issued quarterly. Ms. Bloor received 10,000 RSUs at the initial election, 2,922 RSUs for annual compensation, 480 RSUs as chair of the Compensation Committee, 120 RSUs as member of the Nominating and Corporate Governance Committee and 120 RSUs as member of the Audit Committee - 13,642 RSUs in total. F1 · derivative.expiration_date: On June 10, 2022, the Board of Directors (the "Board") of Creatd, Inc. (the "Company") approved that the independent members of the Board each receive compensation for serving on the Board, in the form of equity issued pursuant to the Creatd, Inc. 2022 Omnibus Securities and Incentive Plan, which remains subject to shareholder approval. The Restricted Stock Units (the "RSUs") issued are priced at fair market value at issuance, vest one year from the date of issuance and are issued quarterly. Ms. Bloor received 10,000 RSUs at the initial election, 2,922 RSUs for annual compensation, 480 RSUs as chair of the Compensation Committee, 120 RSUs as member of the Nominating and Corporate Governance Committee and 120 RSUs as member of the Audit Committee - 13,642 RSUs in total. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.